PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Vyriad Inc, Rochester MN 55901, USA; Imanis Life Sciences, Rochester MN 55901, USA; Department of Molecular Medicine, Mayo Clinic, MN 55905, USA.\', \'Imanis Life Sciences, Rochester MN 55901, USA.\', \'Department of Molecular Medicine, Mayo Clinic, MN 55905, USA.\', \'Vyriad Inc, Rochester MN 55901, USA.\', \'Regeneron Pharmaceuticals Inc, Tarrytown, NY 10591, USA.\', \'Department of Surgery, University of Minnesota, USA.\', \'Vyriad Inc, Rochester MN 55901, USA; Imanis Life Sciences, Rochester MN 55901, USA; Department of Molecular Medicine, Mayo Clinic, MN 55905, USA. Electronic address: sjrussell@vyriad.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)01671-610.1016/j.vaccine.2021.12.063
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 35282925
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35282925>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35282925>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all